FRESENIUS MEDICAL CARE AG (1FME.MI) Stock Price, Forecast & Analysis

BIT:1FME • DE0005785802

40.03 EUR
-0.37 (-0.92%)
Last: Mar 2, 2026, 07:00 PM

1FME.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap23.49B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Shares586.83M
Float412.12M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend1.19
Dividend Yield3.67%
EPS(TTM)3.55
PE11.28
Fwd PE9.65
Earnings (Next)05-05
IPO1996-10-02
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
1FME.MI short term performance overview.The bars show the price performance of 1FME.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20

1FME.MI long term performance overview.The bars show the price performance of 1FME.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1FME.MI is 40.03 EUR.

FRESENIUS MEDICAL CARE AG / 1FME Daily stock chart

1FME.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1FME.MI.


Chartmill TA Rating
Chartmill Setup Rating
1FME.MI Full Technical Analysis Report

1FME.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1FME.MI. 1FME.MI has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1FME.MI Full Fundamental Analysis Report

1FME.MI Financial Highlights

Over the last trailing twelve months 1FME.MI reported a non-GAAP Earnings per Share(EPS) of 3.55. The EPS increased by 9.36% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.98%
ROA 3.16%
ROE 7.35%
Debt/Equity 0.65
Chartmill High Growth Momentum
EPS Q2Q%-22.61%
Sales Q2Q%-1.52%
EPS 1Y (TTM)9.36%
Revenue 1Y (TTM)1.51%
1FME.MI financials

1FME.MI Forecast & Estimates

27 analysts have analysed 1FME.MI and the average price target is 45.83 EUR. This implies a price increase of 14.49% is expected in the next year compared to the current price of 40.03.

For the next year, analysts expect an EPS growth of 16.67% and a revenue growth 2.15% for 1FME.MI


Analysts
Analysts65.93
Price Target45.83 (14.49%)
EPS Next Y16.67%
Revenue Next Year2.15%
1FME.MI Analyst Estimates1FME.MI Analyst Ratings

1FME.MI Ownership

Ownership
Inst Owners43.91%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
1FME.MI Ownership

About 1FME.MI

Company Profile

1FME logo image Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,916 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Company Info

FRESENIUS MEDICAL CARE AG

Else-Kroener-Strasse 1

Bad Homburg vor der Hohe HESSEN DE

Employees: 109916

1FME Company Website

1FME Investor Relations

Phone: 4961726090

FRESENIUS MEDICAL CARE AG / 1FME.MI FAQ

What does 1FME do?

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,916 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.


Can you provide the latest stock price for FRESENIUS MEDICAL CARE AG?

The current stock price of 1FME.MI is 40.03 EUR. The price decreased by -0.92% in the last trading session.


What is the dividend status of FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (1FME.MI) has a dividend yield of 3.67%. The yearly dividend amount is currently 1.19.


What is the ChartMill technical and fundamental rating of 1FME stock?

1FME.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the PE ratio for 1FME stock?

The PE ratio for FRESENIUS MEDICAL CARE AG (1FME.MI) is 11.28. This is based on the reported non-GAAP earnings per share of 3.55 and the current share price of 40.03 EUR.


What is the employee count for 1FME stock?

FRESENIUS MEDICAL CARE AG (1FME.MI) currently has 109916 employees.


Can you provide the market cap for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (1FME.MI) has a market capitalization of 23.49B EUR. This makes 1FME.MI a Large Cap stock.